| Drugs by Condition |  |
Angioedema Medications
Definition of Angioedema: Angioedema is the development of large welts below the surface of the skin, especially around the eyes and lips. The welts may also affect the hands, feet, and throat. The condition can be associated with allergies and histamine release.
Drugs associated with Angioedema
The following drugs and medications are in some way related to, or used in the treatment of Angioedema.
This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug Name  ( View by: Brand | Generic )
|
Reviews | Ratings |
||
|---|---|---|---|---|
Winstrol (More...) generic name: stanozolol class: androgens and anabolic steroids | 0 review(s) | Not rated - Be the first | ||
| Danocrine (Pro, More...)generic name: danazol class: miscellaneous hormones | 0 review(s) | Not rated - Be the first | ||
Angioedema Medications in the Pipeline
Icatibant
- June 23, 2008
Jerini to Submit Complete Response to the FDA for Icatibant in the Treatment of HAE - April 24, 2008
FDA Issues Not Approvable Letter for Icatibant in the Treatment of HAE - January 8, 2008
FDA Cancels Advisory Committee Meeting for Icatibant in the Treatment of HAE - Priority Review of Jerini's NDA Continues - December 21, 2007
Jerini Receives NDA Filing Acceptance and Priority Review from the FDA for Icatibant in the Treatment of HAE - October 31, 2007
Jerini Submits New Drug Application for Icatibant in the Treatment of HAE to the FDA and Requests Priority Review - October 8, 2007
Jerini Initiates FDA Submission Process of New Drug Application for Icatibant in the Treatment of HAE
Rhucin (recombinant human C1 esterase inhibitor)
- January 29, 2008
Pharming Provides Update on Rhucin
Berinert P (C1-esterase inhibitor)
DX-88 (ecallantide)
- June 8, 2009
Dyax Announces FDA Accepts for Review the Complete Response Submission for DX-88 in Hereditary Angioedema - March 27, 2009
Dyax Receives Complete Response Letter from FDA for DX-88 in Acute Attacks of Hereditary Angioedema - February 5, 2009
FDA Advisory Committee Favors Approval of DX-88 for Acute Attacks of Hereditary Angioedema - January 13, 2009
Dyax Announces FDA Advisory Committee to Review DX-88 for Hereditary Angioedema - November 21, 2008
FDA Accepts Filing and Grants Priority Review for DX-88 for Hereditary Angioedema - September 24, 2008
Dyax Announces Completion of Biologics License Application for DX-88 for Hereditary Angioedema
See also
Community Q & A
Ask a Question about Angioedema:Learn more about Angioedema
Medical encyclopedia results for:
